Hence, the ‘sICM storm’ that we observed at the preclinical stages of type 1 diabetes, specifically the high concentrations of sPD-1, may reflect a dysregulated immune activation that may lead to loss of immunological self-tolerance. This evidence concerns the gene HOXD13 and type 1 diabetes mellitus.